↓ Skip to main content

Comparison of two commercial tests (Immy vs. Dynamiker) for cryptococcal capsular antigen

Overview of attention for article published in Revista da Sociedade Brasileira de Medicina Tropical, September 2021
Altmetric Badge

Readers on

mendeley
3 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Comparison of two commercial tests (Immy vs. Dynamiker) for cryptococcal capsular antigen
Published in
Revista da Sociedade Brasileira de Medicina Tropical, September 2021
DOI 10.1590/0037-8682-0307-2021
Pubmed ID
Authors

María Clara Noguera, Patricia Escandón, Javier Rodríguez, Alexander Parody, Leidy Camargo

Abstract

Lateral flow assay is an advanced method useful in the early diagnosis of cryptococcal meningitis. We aimed to compare two commercial tests for cryptococcal capsular antigen in the sera of asymptomatic patients with human immunodeficiency virus in Barranquilla, Colombia. Thawed (n=162) previously collected serums (2016-2019) were processed using IMMY and Dynamiker cryptococcal antigen lateral flow assay. Compared to IMMY's results, Dynamiker's sensitivity, specificity, positive predictive value, negative predictive value, and kappa index were 100%, 89.9%, 48.3%, 100.0%, and 0.61, respectively. The Dynamiker test had excellent sensitivity, acceptable specificity, and a low detection threshold for cryptococcal antigen in the tested samples.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 3 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 3 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 1 33%
Student > Bachelor 1 33%
Unknown 1 33%
Readers by discipline Count As %
Unspecified 1 33%
Pharmacology, Toxicology and Pharmaceutical Science 1 33%
Unknown 1 33%